Forecasts data is unavailable for this security.
Consensus recommendation
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 7 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for CG Oncology Inc have a median target of 65.50, with a high estimate of 86.00 and a low estimate of 52.00. The median estimate represents a 77.12% increase from the last price of 36.98.
High | 132.6% | 86.00 |
Med | 77.1% | 65.50 |
Low | 40.6% | 52.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 12, 2024.
Average growth rate | +35.61% |
More ▼
Revenue history & estimates in USD
Average growth rate | +17,553.24% |
More ▼